<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/320A95D7-E544-4371-ACAC-D706B4093FD6"><gtr:id>320A95D7-E544-4371-ACAC-D706B4093FD6</gtr:id><gtr:firstName>David Anthony</gtr:firstName><gtr:surname>Price</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501963"><gtr:id>0E9AD007-433F-4CC1-975B-A5F9C026746E</gtr:id><gtr:title>Principles of clonal selection in T cell populations undergoing antigen-driven expansion in vivo</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501963</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Adaptive T cell immunity is critical for host defence against intracellular pathogens and tumour
surveillance, yet potentially autoaggressive and aberrantly responsive to inert antigens. Quantitative
measures that characterize the magnitude of antigen-specific responses have largely failed to reveal
consistent correlates of T cell-mediated immune protection or immunopathology; thus, new
approaches that examine qualitative aspects of individual responses are required. The aim of this
proposal is to deconvolute the clonotypic architecture of specific T cell populations responding to
defined antigens in vivo under a spectrum of conditions in order to clarify the basic biological
principles that govern antigen-driven T cell selection in the periphery and to establish the biological
relevance of these processes with respect to the underlying pathology. This will be accomplished
directly ex vivo using a series of novel and sophisticated technologies including point-mutated
peptide-major histocompatibility complex (pMHC) molecules to assess antigen avidity, polychromatic
flow cytometry to determine functional and phenotypic properties at the single cell level, and
quantitative molecular clonotyping with a template-switch anchored RT-PCR to amplify all expressed
TCR gene products in a linear manner without bias; in addition, surface plasmon resonance and
crystallography will be used to characterize TCR/pMHC interactions of interest biophysically and
structurally. The following types of antigen-specific T cell responses will be studied: (i) virus-specific
(dangerous foreign); (ii) tumour-specific (dysregulated self); (iii) alloreactive (foreign self); (iv)
autoreactive (self); (v) allergic (non-dangerous foreign). The resultant data will be mined for
pathophysiological correlates. Additional experiments will investigate new approaches to antigen
delivery that might enable the manipulation of clonotype usage in response to given antigens with
beneficial effect. Ultimately, it is envisioned that this work will inform clinically-relevant translational
vaccinology and immunotherapeutics through a detailed understanding of clonotypic ontogeny
during antigenic challenge and the identification of molecular signatures that characterize both
successful and unsuccessful antigen-specific T cell responses.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3112801</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited Speaker - St. Donat's</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>4912C529-47C6-407A-90A0-9135A9955324</gtr:id><gtr:impact>Price DA (2010). Going with the flow: tricks with tetramers and TCRs. In: Program and Abstracts of the I3 IRG Annual Meeting, St. Donat's, Vale of Glamorgan, UK.

Collaboration</gtr:impact><gtr:outcomeId>SwC486VrDqR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Yokohama</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9767FF16-450F-4485-B384-5958C03BD6CA</gtr:id><gtr:impact>Price DA (2010). Immune monitoring and immune therapy: novel approaches in leukemia. In: Program and Abstracts of the 72nd Annual Meeting of the Japanese Society of Hematology (JSH), Yokohama, Japan.

Collaboration</gtr:impact><gtr:outcomeId>A6FFVowjfUz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Brighton</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E7FD8308-3BAE-4AC3-AABA-2B7D91058207</gtr:id><gtr:impact>Division of Clinical Investigation, Brighton and Sussex Medical School, Brighton, UK

Potential colaboration</gtr:impact><gtr:outcomeId>586E12352D6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Copenhagen</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7CBB03E4-B9A5-4C35-929D-F7C146066040</gtr:id><gtr:impact>Center for Cancer Immune Therapy, Herlev University Hospital, Copenhagen, Denmark

Collaboration</gtr:impact><gtr:outcomeId>ReJ4VC6KJrQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Brisbane</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>2CDC8CC3-E7E0-46EC-A114-1517E778C81F</gtr:id><gtr:impact>Queensland Institute of Medical Research, Brisbane, Queensland, Australia

Collaboration</gtr:impact><gtr:outcomeId>Av2gWDXPKVG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Munich</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>4748C583-B173-4639-A704-09C06AA6357A</gtr:id><gtr:impact>Price DA (2008). Novel reagents for the flow cytometric detection of antigen-specific CD8+ T cell populations with differential avidities. In: Program and Abstracts of the International Flow Cytometry School Meeting, Munich, Germany.

Potential collaboration</gtr:impact><gtr:outcomeId>439DFC0A8DF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - San Francisco</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D1E14F02-91A4-403D-8C87-0A7B67F38646</gtr:id><gtr:impact>Department of Medicine, San Francisco General Hospital, San Francisco CA, USA

Collaboration</gtr:impact><gtr:outcomeId>n121EHQy8Ct</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Freiburg</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>56ED13AC-AE8F-4C4E-852F-FE212DCBAE0D</gtr:id><gtr:impact>Department of Medicine, Freiburg University, Freiburg, Germany

Collaboration</gtr:impact><gtr:outcomeId>6FF54412564</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Miami</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>33E9D4DE-DCDA-4017-B0EB-0665F32A02E2</gtr:id><gtr:impact>Price DA (2008). Avidity grading of antigen-specific CD8+ T cell populations with coreceptor-mutated pMHCI tetramers. In: Program and Abstracts of the 14th Annual Meeting of the International Society for Cellular Therapy (ISCT) [p9], Miami, Florida, USA.

Collaboration</gtr:impact><gtr:outcomeId>2EE1F3AE047</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Nagoya</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>806791B2-7D7A-42EF-B1F1-EF44CD3DC4A7</gtr:id><gtr:impact>Department of Immunology, Nagoya City University School of Medicine, Nagoya, Japan

Collaboration</gtr:impact><gtr:outcomeId>ZEVFBbyP231</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9091FA6F-2035-4303-BFEE-92D049A7A94D</gtr:id><gtr:impact>Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK

Potential collaboration</gtr:impact><gtr:outcomeId>VfLHaTXrttM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Milan</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>76F53271-E0CC-4427-91EA-02BF0E899379</gtr:id><gtr:impact>Istituto Clinico Humanitas, Rozzano, Milan, Italy

Collaboration and supervision of a PhD student</gtr:impact><gtr:outcomeId>LKurrAgAEpK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>545F198A-3782-4602-9C8F-30C968628A4B</gtr:id><gtr:impact>Department of Immunology, Chelsea and Westminster Hospital, Imperial College, London, UK

Potential collaboration</gtr:impact><gtr:outcomeId>9FF97A74519</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Zurich</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8A40FFB8-B047-4FCD-968B-EDE698675AE5</gtr:id><gtr:impact>Institute of Microbiology, ETH Z&amp;uuml;rich, Z&amp;uuml;rich, Switzerland

Collaboration</gtr:impact><gtr:outcomeId>67D9F0B9F19</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Cleveland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>F7F1C54A-C46E-416D-8F4B-A1274643AA02</gtr:id><gtr:impact>Center for Global Health, Case Western Reserve University, Cleveland OH, USA

Collaboration</gtr:impact><gtr:outcomeId>7212657760F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Kunming</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3B89EB10-5679-4E23-9C8C-49CC72470C01</gtr:id><gtr:impact>Price DA, Asher TE, Wilson NA, Nason MC, Brenchley JM, Venturi V, Davenport MP, Watkins DI, Douek DC (2006). Clonotypic correlates of protective vaccine-induced CD8 T cell responses. In: Program and Abstracts of the Chinese Academy of Sciences Morningside Symposium on Primate Research [p19], Kunming, Yunnan, China.

Collaboration</gtr:impact><gtr:outcomeId>166395D7C91</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Selected Presenter - Atlanta</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>23D3374A-AB2B-4A6D-B91F-ADBEE30DE977</gtr:id><gtr:impact>Melenhorst JJ, Scheinberg P, Gostick E, Chattopadhyay PK, Lissina A, Cole DK, Roederer M, Bornstein E, Hensel NF, Douek DC, Sewell AK, Barrett AJ, Price DA (2007). Peptide-major histocompatibility complex class I tetramers with enhanced coreceptor binding properties enable visualization of low avidity leukemia-associated antigen-specific CD8+ T cells. In: Program and Abstracts of the 49th Annual Meeting of the American Society of Hematology (ASH) [p404a; abstract #1343], Atlanta, Georgia, USA.

Collaboration</gtr:impact><gtr:outcomeId>C808048A620</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Dublin</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A5724F3C-F5E7-40AD-ACF5-3BE9026B33DB</gtr:id><gtr:impact>Price DA (2009). Clonotypes and T-cell efficacy: implications for cancer vaccines. In: Program and Abstracts of the Cancer Vaccines/Adjuvants/Delivery for the next Decade (CVADD) Meeting, Dublin, Ireland.

Collaboration</gtr:impact><gtr:outcomeId>849A2C458A9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Warwick</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>979D9339-5AC6-4121-83BE-7884DC126214</gtr:id><gtr:impact>Price DA (2009). Making sense of adaptive T cell immunity: repertoire selection and the antigenic universe. In: Program and Abstracts of the EPSRC Symposium on the Mathematics of Complexity Science and Systems Biology, Warwick Mathematics Research Centre, Warwick, UK.

Collaboration</gtr:impact><gtr:outcomeId>05F022B15F9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Keystone</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>88865122-B9B6-49B4-AD97-0CC22B08FB2C</gtr:id><gtr:impact>Price DA, Asher TE, Wilson NA, Venturi V, Davenport MP, Watkins DI, Douek DC (2009). Deconvoluting adaptive T cell immunity: clonotype selection and biological outcome. In: Program and Abstracts of the Keystone Symposium on Immunologic Memory and Host Defense, Keystone, Colorado, USA.

Potential collaboration</gtr:impact><gtr:outcomeId>755FB5705E5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - El Paso</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>311054B5-4147-4D46-A6E7-98AC4B913D1A</gtr:id><gtr:impact>Border Biomedical Research Center, University of Texas, El Paso TX, USA

Collaboration</gtr:impact><gtr:outcomeId>CD8B61E0561</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - New York</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>63CCBC54-534C-481A-A65F-7E7CF9DE70F3</gtr:id><gtr:impact>IAVI, Brooklyn, New York NY, USA

Collaboration</gtr:impact><gtr:outcomeId>0328B00D5EF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Selected Speaker - Whistler</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>88E0AB5C-3558-4871-925C-F5D86BA498C1</gtr:id><gtr:impact>Price DA, Bitmansour A, Walker JM, Edgar JB, Axthelm MK, Douek DC, Picker LJ (2007). Evolution of cytomegalovirus-specific CD4+ T cell clonotypes in vivo: vaccine design informed by successful immune responses. In: Program and Abstracts of the Keystone Symposium on HIV Vaccines: From Basic Research to Clinical Trials [p95; abstract #343], Whistler, British Columbia, Canada.

Collaboration</gtr:impact><gtr:outcomeId>89839FDFE8F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Osaka</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E96278DE-1DB5-44BB-AA19-139EC5121D29</gtr:id><gtr:impact>Department of Clinical Laboratory Science, Osaka University Medical School, Osaka, Japan

Potential collaboration</gtr:impact><gtr:outcomeId>Z1r5R9833cn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>846CD36B-A7E4-4A8F-B00F-3E98E7903249</gtr:id><gtr:impact>Miltenyi Biotec T-cell Day, Royal College of Pathologists, London

Public dissemination of recent research findings</gtr:impact><gtr:outcomeId>L3BmMoo4DF6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9A7A97B8-C087-464D-9A87-C32F5DC7A69A</gtr:id><gtr:impact>Department of Pathology, Cambridge University, Cambridge, UK

Potential collaboration</gtr:impact><gtr:outcomeId>575822A52F0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Tutor - Mbeya</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>37C98274-0825-4686-A0CC-0E5888A558F9</gtr:id><gtr:impact>Mbeya Medical Research Programme, Tanzania

Training and education of PhD students</gtr:impact><gtr:outcomeId>MDYLH3di7UB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Mbeya</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>F8D6F34F-0043-4ED9-B94C-8623389B6194</gtr:id><gtr:impact>Mbeya Medial Research Programme, Tanzania

Collaboration</gtr:impact><gtr:outcomeId>YZXKuhDvxit</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Sydney</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A7FDA554-DC9F-4F75-BFE2-04D40F438F30</gtr:id><gtr:impact>Centre for Immunology, St. Vincent's Hospital, Sydney, New South Wales, Australia

Collaboration</gtr:impact><gtr:outcomeId>A3FCD23EF22</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Worcester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E24756BF-6866-4B09-9153-3524E9E02012</gtr:id><gtr:impact>Department of Pathology, University of Massachusetts Medical School, Worcester MA, USA

Collaboration</gtr:impact><gtr:outcomeId>94FBBC86F24</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Melbourne</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A81E85D9-5BB4-4FF0-826B-C61F2A83AC4D</gtr:id><gtr:impact>Price DA (2010). Multiparametric profiling of antigen-specific T cell immunity: implications for disease pathogenesis and vaccine development. In: Program and Abstracts of the 3rd Australasian Vaccines &amp;amp; Immunotherapeutics Development (AVID) Meeting, Melbourne, Victoria, Australia.




Collaboration</gtr:impact><gtr:outcomeId>GyhuWULzsjA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - York</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>27E4DD23-5ADE-4847-AFFD-E63EF0970CA9</gtr:id><gtr:impact>Centre for Immunology and Infection, University of York, York, UK

Potential collaboration</gtr:impact><gtr:outcomeId>n6kXJbBNZuD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Strasbourg</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A91A1FF2-2985-40DE-9E28-FF9C8A9FDB33</gtr:id><gtr:impact>Transgene SA, Parc d'Innovation, Strasbourg, France

Potential collaboration</gtr:impact><gtr:outcomeId>qQJceKy33wK</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>A192EA6C-4E0A-494A-B5A2-EDD557E29296</gtr:id><gtr:impact>Department of Infection and Immunity, Guy's Hospital, King's College London, London, UK

Collaboration</gtr:impact><gtr:outcomeId>KriyzuhgZPq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Kisumu</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>0F223A41-A036-4E41-AA1B-EBC6F8BDEEF6</gtr:id><gtr:impact>Kenya Medical Research Institute, Kisumu, Nyanza, Kenya 2007

Collaboration</gtr:impact><gtr:outcomeId>890FB9C3BE8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>577AB17A-C88C-4B4A-9B0C-C2091325439D</gtr:id><gtr:impact>Price DA (2007). Physical detection and characterization of antigen-specific CD8+ T cell populations by flow cytometry. In: Program and Abstracts of the Inaugural Meeting of flowcytometryUK [p14], King's College, Cambridge, UK.

Collaboration</gtr:impact><gtr:outcomeId>06933A59D48</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Utrecht</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>99F3CD1E-3DDC-475C-B9B3-175970B2087F</gtr:id><gtr:impact>Department of Immunology, UMC Utrecht, Netherlands

Collaboration</gtr:impact><gtr:outcomeId>3B53D853A45</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Selected Speaker - Santa Fe</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D3BF3100-4BAF-48EA-8E2C-4F9089BDC50A</gtr:id><gtr:impact>Price DA, Asher TE, Wilson NA, Nason MC, Brenchley JM, Venturi V, Watkins DI, Davenport MP, Douek DC (2007). Public clonotype usage in virus-specific CD8+ T cell populations: mechanisms of TCR sharing and biological implications. In: Program and Abstracts of the Keystone Symposium on Immunological Memory [p92; abstract #311], Santa Fe, New Mexico, USA.

Collaboration</gtr:impact><gtr:outcomeId>23729BC1988</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Antwerp</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>56123A67-5253-41AD-93F8-EC735AF93F5F</gtr:id><gtr:impact>Price DA (2008). High definition flow cytometry for the reliable quantification of antigen-specific CD8+ T cells with peptide-MHC class I tetramers. In: Program and Abstracts of the 1st Regional ISCT Meeting, Antwerp, Belgium.

Collaboration</gtr:impact><gtr:outcomeId>C7ECE43B1D3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - La Plagne</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>5043C2B1-3534-4886-AEF9-9D4884626B8B</gtr:id><gtr:impact>Price DA (2008). Optimized ex vivo detection of low frequency antigen-specific CD8+ T cell populations with peptide-MHC class I tetramers. In: Program and Abstracts of the Measurement of Antigen-Specific Immune Responses (MASIR) Meeting [p66; abstract #S24], La Plagne, France.

Collaboration.</gtr:impact><gtr:outcomeId>43603A7654E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - San Diego</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>CF2F9A9E-73FE-426B-9C58-BAD2DA05E8B1</gtr:id><gtr:impact>Torrey Pines Institute for Molecular Studies, General Atomics Court, San Diego CA, USA 2007

Potential collaboration</gtr:impact><gtr:outcomeId>76979467FA0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>372DD859-EA1B-4864-A687-7B5112FFF1CA</gtr:id><gtr:impact>Division of Infection and Immunity, University College Hospital, London, UK

Potential collaboration</gtr:impact><gtr:outcomeId>B042FAEA28C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Birmingham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>1B142F4C-1F90-4C33-A623-3FA1C2C9D0DB</gtr:id><gtr:impact>Division of Immunity and Infection, Birmingham University, Birmingham, UK

Potential collaboration</gtr:impact><gtr:outcomeId>6933F4DB184</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Fremantle</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>518A02C3-FF22-4ABD-B947-46314A0E4958</gtr:id><gtr:impact>Price DA (2008). Polychromatic flow cytometry for the comprehensive profiling of antigen-specific CD8+ T cell populations: phenotype, function, avidity and clonotypic architecture. In: Program and Abstracts of the 31st AFCG Meeting, Fremantle, Australia.

Potential collaboration</gtr:impact><gtr:outcomeId>7ED9787547D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Toyohashi</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3C7F5DB1-977C-4332-8D39-62EB1E238140</gtr:id><gtr:impact>Choju Medical Institute, Toyohashi, Japan

Collaboration</gtr:impact><gtr:outcomeId>r3Gsw4Lptne</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker - Fremantle</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>60F037E8-A938-471A-9F5A-3CC759D1E7F5</gtr:id><gtr:impact>Price DA (2008). Flow cytometric detection of rare antigen-specific CD8+ T cells. In: Program and Abstracts of the 31st AFCG Meeting, Fremantle, Australia.

Potential collaboration</gtr:impact><gtr:outcomeId>77E8E537A4F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Melbourne</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>BC3B574C-5F75-4D99-90E6-BDAA16BB7863</gtr:id><gtr:impact>Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia

Collaboration</gtr:impact><gtr:outcomeId>NMamfk2SAhc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Baltimore</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6871BCA8-2893-4DF2-85DB-507CDC6CB302</gtr:id><gtr:impact>Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine

Collaboration</gtr:impact><gtr:outcomeId>sn56QLwavxu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker - Bristol</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B99B00C3-96C8-4674-B32C-F2C78242ECA0</gtr:id><gtr:impact>BSI Vaccine Affinity Group Symposium, University of Bristol, Bristol, UK

Potential collaboration</gtr:impact><gtr:outcomeId>e7oMkU6XSP7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2932789</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LoLa Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/H001085/1</gtr:fundingRef><gtr:id>0F26177F-ACD2-43C7-B19A-239ECB6EFBBE</gtr:id><gtr:outcomeId>EgSGURxUVHL0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Application of polymer-based dyes as fluorophores for immunophenotyping of antigen-specific T-cells by flow cytometry</gtr:description><gtr:id>AE4E92EB-64CB-4804-B486-5EE9C8F7DDD9</gtr:id><gtr:impact>Enhanced resolution of multiple antigen-specific T-cell populations in polychromatic flow cytometry experiments</gtr:impact><gtr:outcomeId>YCL81JNt3L7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Polymer dye peptide-MHC tetramers</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Application of semiconductor nanocrystals as fluorophores for immunophenotyping of antigen-specific T-cells by flow cytometry</gtr:description><gtr:id>F888CB47-87A3-4EE7-B4FE-71457EC42E63</gtr:id><gtr:impact>The advancement of polychromatic flow cytometry from 13 to 18 fluorescent parameters</gtr:impact><gtr:outcomeId>906DE95CF5C</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Quantum dot peptide-MHC tetramers</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C7875F82-624E-4F27-BD29-78BCAFFF5387</gtr:id><gtr:title>The T cell repertoire in infection and vaccination: implications for control of persistent viruses.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1700a73c2a1a52c0cb9ee2512988b2b0"><gtr:id>1700a73c2a1a52c0cb9ee2512988b2b0</gtr:id><gtr:otherNames>Davenport MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>73549196045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>899AE6BA-5604-4C7D-886E-EA5109C2BE3C</gtr:id><gtr:title>Structural and biophysical determinants of a? T-cell antigen recognition.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/608e9c0e34392a2481e8e9fcee956b26"><gtr:id>608e9c0e34392a2481e8e9fcee956b26</gtr:id><gtr:otherNames>Bridgeman JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>pm_12476_26_22044041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABD3FC50-2CD0-4033-B2F8-A28595E03AEA</gtr:id><gtr:title>Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81c9fb8b0ffb5571fb70a5f49d58f1c4"><gtr:id>81c9fb8b0ffb5571fb70a5f49d58f1c4</gtr:id><gtr:otherNames>Daucher M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>1D13173DF80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1054A9B2-A6C6-407E-8795-D8FB927A5D10</gtr:id><gtr:title>Mechanisms underlying ?d T-cell subset perturbations in SIV-infected Asian rhesus macaques.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14d1faaeeb4d10e6e11cd3c80c695b6f"><gtr:id>14d1faaeeb4d10e6e11cd3c80c695b6f</gtr:id><gtr:otherNames>Harris LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>mRqtyW1USGP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA1B4D9B-119E-4A65-87F7-896A1B93048D</gtr:id><gtr:title>Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1baa03f79f0057534df0cd4ac94fd949"><gtr:id>1baa03f79f0057534df0cd4ac94fd949</gtr:id><gtr:otherNames>Bimber BN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>1BC06FC6DA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78C2B61C-9E46-4102-AEDE-16E2A52DF2AC</gtr:id><gtr:title>A mechanism for TCR sharing between T cell subsets and individuals revealed by pyrosequencing.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f5676bad8e51dedd8e69c5b564efbd"><gtr:id>64f5676bad8e51dedd8e69c5b564efbd</gtr:id><gtr:otherNames>Venturi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>d2LNH4cnbyM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C5035D0-7AA3-4B00-B72D-4C7B0277811F</gtr:id><gtr:title>Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1ea982163d0726daa0974c5fc5467b"><gtr:id>0b1ea982163d0726daa0974c5fc5467b</gtr:id><gtr:otherNames>Brenchley JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5CA4100261A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4E19BE-61E7-4411-AE8A-0C967D5D97E1</gtr:id><gtr:title>Conditional CD8+ T cell escape during acute simian immunodeficiency virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a96081bc737c666c90b62c3f6386d296"><gtr:id>a96081bc737c666c90b62c3f6386d296</gtr:id><gtr:otherNames>O'Connor SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12476_26_22013056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A76B38C1-34EE-4CC4-B4CD-535DFBAE4DBF</gtr:id><gtr:title>Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a610b8cc0953c3fc751032a93b0d84f"><gtr:id>7a610b8cc0953c3fc751032a93b0d84f</gtr:id><gtr:otherNames>Price DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>70559A8D48E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41CEFC3F-AF3D-4C5E-B546-99BD9B34F109</gtr:id><gtr:title>IL-10 restricts memory T cell inflation during cytomegalovirus infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>m2goJQpQzsn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41E9F97A-8D8D-4276-8202-ED99C3363DD1</gtr:id><gtr:title>Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6dc8910324a5dc6c58b9fae087cba8e"><gtr:id>c6dc8910324a5dc6c58b9fae087cba8e</gtr:id><gtr:otherNames>Rosario M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>hATHyYmEqPS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CFC42B5-9AF9-4493-959A-40EE3D892EA4</gtr:id><gtr:title>Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd0905429230adf241afc2cae39e1542"><gtr:id>cd0905429230adf241afc2cae39e1542</gtr:id><gtr:otherNames>Melenhorst JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>XCgb5gaVgcC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A3E43B3-58E8-480B-A03C-74D9FC11EEAB</gtr:id><gtr:title>Unbiased molecular analysis of T cell receptor expression using template-switch anchored RT-PCR.</gtr:title><gtr:parentPublicationTitle>Current protocols in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5bc0f3d161e07aa60de00bad1082433"><gtr:id>b5bc0f3d161e07aa60de00bad1082433</gtr:id><gtr:otherNames>Quigley MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1934-3671</gtr:issn><gtr:outcomeId>pS92ebsGBbC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99577CDE-8B93-40BD-945F-3B45E178897E</gtr:id><gtr:title>SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/833871a2c9f973bae8866fd14b00c736"><gtr:id>833871a2c9f973bae8866fd14b00c736</gtr:id><gtr:otherNames>Petrovas C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>FD6F75CC14F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FD0D70D-308A-4B30-88A7-FBCDACBD14A4</gtr:id><gtr:title>The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6d1393dc2eefe070ba1cd2394a1522c"><gtr:id>c6d1393dc2eefe070ba1cd2394a1522c</gtr:id><gtr:otherNames>Scheinberg P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>88889DEBF9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B66F319-3B53-4B4F-A3A8-430F23D96B01</gtr:id><gtr:title>The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor.</gtr:title><gtr:parentPublicationTitle>Molecular cancer therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb29b040376b76696745a34577be0cc2"><gtr:id>eb29b040376b76696745a34577be0cc2</gtr:id><gtr:otherNames>Purbhoo MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1535-7163</gtr:issn><gtr:outcomeId>EC67D8DCFAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2645B07-598F-4DB9-AEC1-A13DAF791BB5</gtr:id><gtr:title>CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1cd528ca89a12d59e44186f2e5891f"><gtr:id>3c1cd528ca89a12d59e44186f2e5891f</gtr:id><gtr:otherNames>Laugel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>ECB3AAFDAA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>487EF066-642D-4B45-BEC6-1F00237EA4F1</gtr:id><gtr:title>Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5bc0f3d161e07aa60de00bad1082433"><gtr:id>b5bc0f3d161e07aa60de00bad1082433</gtr:id><gtr:otherNames>Quigley MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>cU28EmbpUL4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43A10501-2525-48C3-8F82-65F9616BD574</gtr:id><gtr:title>Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3345e5272c69fffd0b5425246eaad2fd"><gtr:id>3345e5272c69fffd0b5425246eaad2fd</gtr:id><gtr:otherNames>Honda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>66284C6AE20</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39484BA0-8EAC-40D8-A8C5-0C54321409C6</gtr:id><gtr:title>Macaques vaccinated with live-attenuated SIV control replication of heterologous virus.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f861d4b3048d525ad21fefe7236979f"><gtr:id>3f861d4b3048d525ad21fefe7236979f</gtr:id><gtr:otherNames>Reynolds MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>7A2560819D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>127305D9-2AC3-4CF5-9FA5-1338E62E8915</gtr:id><gtr:title>Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785a93607b178145c66d307b63ab8458"><gtr:id>785a93607b178145c66d307b63ab8458</gtr:id><gtr:otherNames>Giannopoulos K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>gYqw2p43BnA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43594F9F-5A52-4170-8069-D01DE001141D</gtr:id><gtr:title>Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/833871a2c9f973bae8866fd14b00c736"><gtr:id>833871a2c9f973bae8866fd14b00c736</gtr:id><gtr:otherNames>Petrovas C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>0F46F17C946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57874C6F-604E-4BAF-8DA7-43966834CD29</gtr:id><gtr:title>Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d9b889647dcd986dd0bc3b562ff8b3f"><gtr:id>2d9b889647dcd986dd0bc3b562ff8b3f</gtr:id><gtr:otherNames>Schaubert KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>otCd2YrQvvv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50441191-6677-4A18-8805-76E9CDAB050B</gtr:id><gtr:title>Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/246d843e37510a3a54f0e2764657203b"><gtr:id>246d843e37510a3a54f0e2764657203b</gtr:id><gtr:otherNames>Hindley JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>ZpLqRWVixjt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BC9A1CA-BA99-48C6-8B56-D237F05731EE</gtr:id><gtr:title>Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers.</gtr:title><gtr:parentPublicationTitle>Cytometry. Part A : the journal of the International Society for Analytical Cytology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4a9129b422b0a859f595824afc4bd31"><gtr:id>d4a9129b422b0a859f595824afc4bd31</gtr:id><gtr:otherNames>Chattopadhyay PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1552-4922</gtr:issn><gtr:outcomeId>93F034DC18A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDC03982-2AC5-4E15-B87B-3C7D0FBA07DC</gtr:id><gtr:title>The molecular basis for public T-cell responses?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f5676bad8e51dedd8e69c5b564efbd"><gtr:id>64f5676bad8e51dedd8e69c5b564efbd</gtr:id><gtr:otherNames>Venturi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>60AD5DE4FB0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF229967-CDDD-4E21-A61A-12BDC36429F7</gtr:id><gtr:title>Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>Gen3hwLUDzE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D70025B-B2E6-4D34-8EAB-BE84646137BB</gtr:id><gtr:title>TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f5676bad8e51dedd8e69c5b564efbd"><gtr:id>64f5676bad8e51dedd8e69c5b564efbd</gtr:id><gtr:otherNames>Venturi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>6C9228ED29D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F61B498-0066-4BF4-A5CF-DDBA8929FAB4</gtr:id><gtr:title>Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>273DBCF63AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E95C52FA-F26F-434D-B2BC-E3A7E7ECFBEC</gtr:id><gtr:title>Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92bb6246538a5046f7815acad7cdff5e"><gtr:id>92bb6246538a5046f7815acad7cdff5e</gtr:id><gtr:otherNames>Geldmacher C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>D94F4492AE5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B3FE380-2D65-48F6-8BD6-F058D7DCC70D</gtr:id><gtr:title>The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1cd528ca89a12d59e44186f2e5891f"><gtr:id>3c1cd528ca89a12d59e44186f2e5891f</gtr:id><gtr:otherNames>Laugel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>bWjuCQByG8z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A121A3E-4C4E-43A3-A764-42E66F539E3D</gtr:id><gtr:title>Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GvL activity.</gtr:title><gtr:parentPublicationTitle>Cytotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/234d5bc1f623b6837834e29975ccab92"><gtr:id>234d5bc1f623b6837834e29975ccab92</gtr:id><gtr:otherNames>Rezvani K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1465-3249</gtr:issn><gtr:outcomeId>59C3177D0C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56EE767B-8253-40C4-8FF0-89D8F72D9BDF</gtr:id><gtr:title>Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6ac6474b09d998ffaabb9f79d3a19ab"><gtr:id>d6ac6474b09d998ffaabb9f79d3a19ab</gtr:id><gtr:otherNames>Nagai K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_12476_26_22025529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F56EBF25-0FE0-4344-AE0F-DEF1CD172389</gtr:id><gtr:title>GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6b7b1a26b03114338c6963a84d22813"><gtr:id>d6b7b1a26b03114338c6963a84d22813</gtr:id><gtr:otherNames>Vojnov L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>HxjEzzu9ys6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52E66C33-1A75-401C-941E-297F3F686F1A</gtr:id><gtr:title>AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f871d38be2fa92469ef52a7f2e73d1c7"><gtr:id>f871d38be2fa92469ef52a7f2e73d1c7</gtr:id><gtr:otherNames>Maness NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>A0F683B76EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E234676-554E-4A15-BD4C-7CCFAB1A1080</gtr:id><gtr:title>Contribution of TCR-beta locus and HLA to the shape of the mature human Vbeta repertoire.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd0905429230adf241afc2cae39e1542"><gtr:id>cd0905429230adf241afc2cae39e1542</gtr:id><gtr:otherNames>Melenhorst JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>EA223D586A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B2ADCE0-D34C-4FAC-B343-6AE92F7CA95E</gtr:id><gtr:title>Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5486fe0dc75250fe8e9f01c3a5b9106"><gtr:id>a5486fe0dc75250fe8e9f01c3a5b9106</gtr:id><gtr:otherNames>Smith MZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>B7BA8A1FAA7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F011AEDE-BA9D-43DC-A0AD-877E66F4E180</gtr:id><gtr:title>Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bd08c46a146dfed22599afe916f81b3"><gtr:id>9bd08c46a146dfed22599afe916f81b3</gtr:id><gtr:otherNames>Precopio ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>683B5AE6565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C15551BF-5BA0-4CAF-A4BB-BAD83DA6AE7D</gtr:id><gtr:title>MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>naqa2w6zdbr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>807A5D29-9FE7-4622-A222-8262B68FC6A7</gtr:id><gtr:title>Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5282d1f1a1c8d6855a12df70b7c717ec"><gtr:id>5282d1f1a1c8d6855a12df70b7c717ec</gtr:id><gtr:otherNames>Rehr M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>BF9D294557C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CC5D2C4-DABF-4CBC-AF05-201B444241D2</gtr:id><gtr:title>The role of production frequency in the sharing of simian immunodeficiency virus-specific CD8+ TCRs between macaques.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f5676bad8e51dedd8e69c5b564efbd"><gtr:id>64f5676bad8e51dedd8e69c5b564efbd</gtr:id><gtr:otherNames>Venturi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>B8342F2A1CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>743C9E7E-11E3-46F0-AD66-B2D4A5B67162</gtr:id><gtr:title>High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1ea982163d0726daa0974c5fc5467b"><gtr:id>0b1ea982163d0726daa0974c5fc5467b</gtr:id><gtr:otherNames>Brenchley JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>86E7E544557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC72B4AB-5A8C-4308-94FD-96E64B6D33A4</gtr:id><gtr:title>Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6edc06d7812e3af8a6dd2a5512371a3a"><gtr:id>6edc06d7812e3af8a6dd2a5512371a3a</gtr:id><gtr:otherNames>Beveridge NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>487EC423E0E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B69A1C6E-4228-4AE6-AF41-F04608EBD3ED</gtr:id><gtr:title>Induction and evolution of cytomegalovirus-specific CD4+ T cell clonotypes in rhesus macaques.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a610b8cc0953c3fc751032a93b0d84f"><gtr:id>7a610b8cc0953c3fc751032a93b0d84f</gtr:id><gtr:otherNames>Price DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>6FE7E0346A1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEFC270A-51CF-43D3-A898-4E7D6C04F193</gtr:id><gtr:title>Structural basis of diverse peptide accommodation by the rhesus macaque MHC class I molecule Mamu-B*17: insights into immune protection from simian immunodeficiency virus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1ae91a136cc1808e002adb45e242f69"><gtr:id>e1ae91a136cc1808e002adb45e242f69</gtr:id><gtr:otherNames>Wu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_12476_26_22084443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>525CFD1A-2634-4AF7-AF8F-A83CE8FDB23D</gtr:id><gtr:title>High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd0905429230adf241afc2cae39e1542"><gtr:id>cd0905429230adf241afc2cae39e1542</gtr:id><gtr:otherNames>Melenhorst JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>0D42050FC83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B057D45-059E-4C43-B547-57C4B9B5480E</gtr:id><gtr:title>Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation.</gtr:title><gtr:parentPublicationTitle>Leukemia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7067c46cf7efd647dfe7c475bfd10094"><gtr:id>7067c46cf7efd647dfe7c475bfd10094</gtr:id><gtr:otherNames>Kreutzman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0887-6924</gtr:issn><gtr:outcomeId>dFRqKZjeD3z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0AFC1D5-9D5D-4FB2-8EC2-0E34AA35D28B</gtr:id><gtr:title>Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f6a9cac56ccb45c86a642498a7afd40"><gtr:id>6f6a9cac56ccb45c86a642498a7afd40</gtr:id><gtr:otherNames>Nakamoto N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>A9E8E618A06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4C8E1CE-8B8E-4DC6-8FC6-42BDE6F8D9E0</gtr:id><gtr:title>Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a376d7a44129a40b0d1acd302b269f"><gtr:id>26a376d7a44129a40b0d1acd302b269f</gtr:id><gtr:otherNames>Yuan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>0A08742886C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EF834CE-B0F2-4884-94E5-4043C6A2C0A1</gtr:id><gtr:title>Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in culture.</gtr:title><gtr:parentPublicationTitle>Cytotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd0905429230adf241afc2cae39e1542"><gtr:id>cd0905429230adf241afc2cae39e1542</gtr:id><gtr:otherNames>Melenhorst JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1465-3249</gtr:issn><gtr:outcomeId>B3265C3452E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D23EE38B-3D76-4356-9A45-E41C6764B91E</gtr:id><gtr:title>HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29f509404a29582e70ed86b856c70283"><gtr:id>29f509404a29582e70ed86b856c70283</gtr:id><gtr:otherNames>Du VY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a3248d6b03855.39054759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC4E9B83-6C72-4154-BBE9-FAD3F51451C5</gtr:id><gtr:title>Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0e462ca7fccd7fbc45634912abb28f8"><gtr:id>a0e462ca7fccd7fbc45634912abb28f8</gtr:id><gtr:otherNames>Lissina A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>D819E66513D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBA65706-334F-40D0-9AA4-D1E5BA29739B</gtr:id><gtr:title>Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5403befe28412d435c4c4b5320b2269f"><gtr:id>5403befe28412d435c4c4b5320b2269f</gtr:id><gtr:otherNames>Van Tendeloo VF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>bd8hVMEazrN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29FD6156-BE82-47F0-BFF2-92D9AB279A9B</gtr:id><gtr:title>Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/234d5bc1f623b6837834e29975ccab92"><gtr:id>234d5bc1f623b6837834e29975ccab92</gtr:id><gtr:otherNames>Rezvani K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>450CF5E88E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1EDCD86-EF32-40E9-9D15-418B3FC6BBDA</gtr:id><gtr:title>Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ac045cb9e4b94fd865dcc9a589c99af"><gtr:id>9ac045cb9e4b94fd865dcc9a589c99af</gtr:id><gtr:otherNames>Subramanya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>kbgiXaAYRmh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71EFD07A-4521-469E-90DA-A2EBA850E636</gtr:id><gtr:title>Bias in the a? T-cell repertoire: implications for disease pathogenesis and vaccination.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/312af8f4a0e08b0d2cd5cfe5db91775d"><gtr:id>312af8f4a0e08b0d2cd5cfe5db91775d</gtr:id><gtr:otherNames>Miles JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>mUwovy8rNfU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE7E3D34-9E7E-4C24-8CB8-7D924B8E2E78</gtr:id><gtr:title>Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1cd528ca89a12d59e44186f2e5891f"><gtr:id>3c1cd528ca89a12d59e44186f2e5891f</gtr:id><gtr:otherNames>Laugel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>0E8097C60E9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5083DEC-6A85-4FFE-9171-CB036CDC4A6D</gtr:id><gtr:title>Escape from highly effective public CD8+ T-cell clonotypes by HIV.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8a7251bfedfa39ffab15ab20d03273e5"><gtr:id>8a7251bfedfa39ffab15ab20d03273e5</gtr:id><gtr:otherNames>Iglesias MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>DAL7wGzSkRF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>021F3880-E4B6-43F2-90FE-AAED0BCDA9A8</gtr:id><gtr:title>A single autoimmune T cell receptor recognizes more than a million different peptides.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12476_26_22102287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ADDE612-811B-4B63-B10B-2E1E454645C3</gtr:id><gtr:title>Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2faab7cc3a771785ca27ba812a1a1351"><gtr:id>2faab7cc3a771785ca27ba812a1a1351</gtr:id><gtr:otherNames>Hryniewicz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>3867BA86E35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13177FA8-4F97-4AC7-8D0E-B824EADF4D0C</gtr:id><gtr:title>A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bca9710e3dc0a25e25fb349bdbc954e"><gtr:id>2bca9710e3dc0a25e25fb349bdbc954e</gtr:id><gtr:otherNames>Mielke S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>4A2351711C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C7E7545-CF44-421C-8040-7C97F3F774DE</gtr:id><gtr:title>Human TCR-binding affinity is governed by MHC class restriction.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>F711086DE5E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>492B4BC0-BDDF-48F2-A3AD-26DE4C6201C0</gtr:id><gtr:title>Extralymphoid CD8+ T cells resident in tissue from simian immunodeficiency virus SIVmac239{Delta}nef-vaccinated macaques suppress SIVmac239 replication ex vivo.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27de0fb3bd6bfc6f2330bc0b4c94c9af"><gtr:id>27de0fb3bd6bfc6f2330bc0b4c94c9af</gtr:id><gtr:otherNames>Greene JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pHKY9akZaMP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD8B381E-E8B7-4648-B7AB-B6AFCD32E9CD</gtr:id><gtr:title>The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4a9129b422b0a859f595824afc4bd31"><gtr:id>d4a9129b422b0a859f595824afc4bd31</gtr:id><gtr:otherNames>Chattopadhyay PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>DEF3219DF75</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>027C4716-058A-400D-BE97-6A47CA2AF4FD</gtr:id><gtr:title>Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b71c93b892436c62ab719df9f416a581"><gtr:id>b71c93b892436c62ab719df9f416a581</gtr:id><gtr:otherNames>Humphreys IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Zn1dRJTUx6S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EC54F89-6DB0-4543-94F7-D46B74C88E1E</gtr:id><gtr:title>CD8 controls T cell cross-reactivity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>itRan4XmHe2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48E4CC7D-8EBE-48CE-987D-847A99D58C7E</gtr:id><gtr:title>Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fc1fb80befb2de5a814f3ad56a21bd5"><gtr:id>9fc1fb80befb2de5a814f3ad56a21bd5</gtr:id><gtr:otherNames>van Bockel D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>DF6143207B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CE69DFE-96F2-4445-8210-45EC588AB50A</gtr:id><gtr:title>Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63466414c14936dc33d58054af06dbe3"><gtr:id>63466414c14936dc33d58054af06dbe3</gtr:id><gtr:otherNames>Yamamoto T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>hUgJ7Q8psyS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F33EDDB-EF2B-4B40-BD79-B7D20C0CE8CC</gtr:id><gtr:title>CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f6b16ed58112d6a181ef37a0e8327c"><gtr:id>69f6b16ed58112d6a181ef37a0e8327c</gtr:id><gtr:otherNames>Loffredo JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>BB311AE4F37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4DC3EDF-8451-43DE-9847-20AECB7753C2</gtr:id><gtr:title>A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcc880019a9ee418d456ab293e7720ae"><gtr:id>fcc880019a9ee418d456ab293e7720ae</gtr:id><gtr:otherNames>Minassian AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn><gtr:outcomeId>pm_12476_26_22102640</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21ECCBCB-38CA-4BF0-A881-BF65869F98CD</gtr:id><gtr:title>Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6dc8910324a5dc6c58b9fae087cba8e"><gtr:id>c6dc8910324a5dc6c58b9fae087cba8e</gtr:id><gtr:otherNames>Rosario M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>UVSrvj5z77o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5972DE5-0AB8-4861-A203-641691A29F6F</gtr:id><gtr:title>Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c086cf57166823f47a0a3f368315a4bb"><gtr:id>c086cf57166823f47a0a3f368315a4bb</gtr:id><gtr:otherNames>Casazza JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>54636884324142.69508161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CC5739A-C4DE-4E0D-A3F6-5199CEC94B44</gtr:id><gtr:title>Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d57d509139b746ee69e9ea9d00ab3f3f"><gtr:id>d57d509139b746ee69e9ea9d00ab3f3f</gtr:id><gtr:otherNames>Ebinuma H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>C09F33505C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACE51196-754B-4E60-8D53-3D4CD0387C93</gtr:id><gtr:title>Isolation of viable antigen-specific CD8+ T cells based on membrane-bound tumor necrosis factor (TNF)-a expression.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/161108808c676d0d5fa746c039867f1a"><gtr:id>161108808c676d0d5fa746c039867f1a</gtr:id><gtr:otherNames>Haney D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>rjhF5ZDYqft</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E952AE9C-871B-4263-8196-6CB925A93D6A</gtr:id><gtr:title>Extraction and characterization of the rhesus macaque T-cell receptor beta-chain genes.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a93d2c543309c3127722be8d53d8386"><gtr:id>9a93d2c543309c3127722be8d53d8386</gtr:id><gtr:otherNames>Greenaway HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>06A370F079F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6E9802C-4209-4E1E-8CB5-59D30E6C05DF</gtr:id><gtr:title>Profound inhibition of antigen-specific T-cell effector functions by dasatinib.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/705fcb7ad69a3ff4facaa71b8f53924a"><gtr:id>705fcb7ad69a3ff4facaa71b8f53924a</gtr:id><gtr:otherNames>Weichsel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>0A5F775CF55</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00AADC05-2DE0-4EB5-A91C-85EC42FFD4F0</gtr:id><gtr:title>Peptide length determines the outcome of TCR/peptide-MHCI engagement.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/992b542acd15f78e277d8de28fa4f4e7"><gtr:id>992b542acd15f78e277d8de28fa4f4e7</gtr:id><gtr:otherNames>Ekeruche-Makinde J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_12476_26_23255554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D8325F2-F80D-4D7C-A99F-413F15769956</gtr:id><gtr:title>Functional and biophysical characterization of an HLA-A*6801-restricted HIV-specific T cell receptor.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e583b0148c989385edfb47a89732c067"><gtr:id>e583b0148c989385edfb47a89732c067</gtr:id><gtr:otherNames>Gostick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>7F7C3527D24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1264EDC0-404D-42B2-A2D7-F3EEDF4691FD</gtr:id><gtr:title>Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update.</gtr:title><gtr:parentPublicationTitle>Cytotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a4152b2adbb1f92f805e0fa4d1f9e2"><gtr:id>26a4152b2adbb1f92f805e0fa4d1f9e2</gtr:id><gtr:otherNames>Seggewiss R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1465-3249</gtr:issn><gtr:outcomeId>DA94CF0E020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11FF5D49-88CB-4922-A7DE-953CF6DF1B6C</gtr:id><gtr:title>T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/712347860f9fac22c28aa8954dcad82d"><gtr:id>712347860f9fac22c28aa8954dcad82d</gtr:id><gtr:otherNames>Sloand EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>GVFRfgsBKTA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C50BD9B-0F5F-43E3-9BE1-DAE1E806FE53</gtr:id><gtr:title>Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/178358a3892e8dc84cd7a5c2e81924a8"><gtr:id>178358a3892e8dc84cd7a5c2e81924a8</gtr:id><gtr:otherNames>Janbazian L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_12476_26_22210916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAF0F94F-C700-4609-89DA-479422B5D7C5</gtr:id><gtr:title>High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de05bd25db2596472384d4690d61955a"><gtr:id>de05bd25db2596472384d4690d61955a</gtr:id><gtr:otherNames>Berger CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>HCY6WsCG6jp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56EA6E54-3FE8-46A8-B004-70B55E01507A</gtr:id><gtr:title>Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5503eaa9116a55fcbdf41868c7313266"><gtr:id>5503eaa9116a55fcbdf41868c7313266</gtr:id><gtr:otherNames>Almeida JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>912252AC8FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B91DF1F2-870A-4C63-9EFD-A9792D994BFA</gtr:id><gtr:title>Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5503eaa9116a55fcbdf41868c7313266"><gtr:id>5503eaa9116a55fcbdf41868c7313266</gtr:id><gtr:otherNames>Almeida JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>7B2880C6F30</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24E342DB-700E-40AB-B913-BFD76B2A8331</gtr:id><gtr:title>Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f6a9cac56ccb45c86a642498a7afd40"><gtr:id>6f6a9cac56ccb45c86a642498a7afd40</gtr:id><gtr:otherNames>Nakamoto N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>D6559F1090C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53093898-2F25-42D1-A978-75B8C975AD38</gtr:id><gtr:title>OMIP-002: Phenotypic analysis of specific human CD8+ T-cells using peptide-MHC class I multimers for any of four epitopes.</gtr:title><gtr:parentPublicationTitle>Cytometry. Part A : the journal of the International Society for Analytical Cytology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4a9129b422b0a859f595824afc4bd31"><gtr:id>d4a9129b422b0a859f595824afc4bd31</gtr:id><gtr:otherNames>Chattopadhyay PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4922</gtr:issn><gtr:outcomeId>d12rU3ATis2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E64168F8-7972-4080-AD21-B7C2DCA97AEC</gtr:id><gtr:title>Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd0905429230adf241afc2cae39e1542"><gtr:id>cd0905429230adf241afc2cae39e1542</gtr:id><gtr:otherNames>Melenhorst JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>DDE4445DD84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E31AF67D-A106-4446-8613-568B4D363BCF</gtr:id><gtr:title>Tricks with tetramers: how to get the most from multimeric peptide-MHC.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>B823445D846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF34807A-2C79-43CB-89F1-C661BFE9F5B2</gtr:id><gtr:title>Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2eb6466ac1e8a55c77f1ddbc52d438a"><gtr:id>e2eb6466ac1e8a55c77f1ddbc52d438a</gtr:id><gtr:otherNames>Vivian JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_12476_26_22020283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A79E413-5F8A-45FB-BB0F-5B92B24C073D</gtr:id><gtr:title>Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c49d1a70d043595a4281419c5d506e8e"><gtr:id>c49d1a70d043595a4281419c5d506e8e</gtr:id><gtr:otherNames>van Bockel DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>Q1Nz4wiRAXo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DFB310F-44FC-4FE4-A28B-3CDB8648BAB1</gtr:id><gtr:title>CD8+ T cell efficacy in vaccination and disease.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb522a546e15789665d0484a1743ad3"><gtr:id>dfb522a546e15789665d0484a1743ad3</gtr:id><gtr:otherNames>Appay V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>C57EF13DD57</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50461DEF-CFAF-41D7-8BDD-AA812BAB8C78</gtr:id><gtr:title>Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/312af8f4a0e08b0d2cd5cfe5db91775d"><gtr:id>312af8f4a0e08b0d2cd5cfe5db91775d</gtr:id><gtr:otherNames>Miles JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>fJCnduWFP5o</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C71B7F3A-1C8D-4B42-93DA-0DDE6D30F65E</gtr:id><gtr:title>Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa5f96406646bfba5f1c576f6df505ae"><gtr:id>fa5f96406646bfba5f1c576f6df505ae</gtr:id><gtr:otherNames>Ruckwardt TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_12476_26_22144888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45D48C45-6388-4D34-9AE0-8E597B3D0D90</gtr:id><gtr:title>Immunodominance of HLA-A2-restricted hepatitis C virus-specific CD8+ T cell responses is linked to naive-precursor frequency.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eea91874138d0a721399a9c56b7aac16"><gtr:id>eea91874138d0a721399a9c56b7aac16</gtr:id><gtr:otherNames>Schmidt J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>ZjtLDwQn2hP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C565E2C-88A0-4260-94A4-75DA13E53C60</gtr:id><gtr:title>Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaques.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44958ebd82bccf32baa9b2ba4d328386"><gtr:id>44958ebd82bccf32baa9b2ba4d328386</gtr:id><gtr:otherNames>Burwitz BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>W779aC8kNJF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>767F41B9-BF1B-498B-906A-78355A3E6D83</gtr:id><gtr:title>Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>39B4C109FBE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF4DA46C-49B1-42C4-A6ED-8334E6BA8B53</gtr:id><gtr:title>Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d9b889647dcd986dd0bc3b562ff8b3f"><gtr:id>2d9b889647dcd986dd0bc3b562ff8b3f</gtr:id><gtr:otherNames>Schaubert KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>A5994F69A9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31836D83-6950-42E5-8E33-5DC1A96A5BCA</gtr:id><gtr:title>The clonal composition of human CD4+CD25+Foxp3+ cells determined by a comprehensive DNA-based multiplex PCR for TCRB gene rearrangements.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6d1393dc2eefe070ba1cd2394a1522c"><gtr:id>c6d1393dc2eefe070ba1cd2394a1522c</gtr:id><gtr:otherNames>Scheinberg P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>328E8735414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BF2EF27-0CE6-4A70-B2C2-5A480D073FE7</gtr:id><gtr:title>Holoendemic malaria exposure is associated with altered Epstein-Barr virus-specific CD8(+) T-cell differentiation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4a9129b422b0a859f595824afc4bd31"><gtr:id>d4a9129b422b0a859f595824afc4bd31</gtr:id><gtr:otherNames>Chattopadhyay PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_12476_26_23175378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F76C5229-93C2-42CD-A4B4-7D49ABBC6B90</gtr:id><gtr:title>A human memory T cell subset with stem cell-like properties.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48fb17df73bdfd1311d0c2f10011e617"><gtr:id>48fb17df73bdfd1311d0c2f10011e617</gtr:id><gtr:otherNames>Gattinoni L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>ZEgM4aZneUJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94AF51A4-2782-4DA8-9275-F5D5814E272A</gtr:id><gtr:title>Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/351ed424de6aa5f9b10ae98d895756db"><gtr:id>351ed424de6aa5f9b10ae98d895756db</gtr:id><gtr:otherNames>Clement M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>m479YFchX29</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A698FDAA-2A47-4F08-9B49-34114A6B148E</gtr:id><gtr:title>Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54377b5e366d3e8042aa428984c1172b"><gtr:id>54377b5e366d3e8042aa428984c1172b</gtr:id><gtr:otherNames>Falkenburg WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>D3YYHw9wfPY</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501963</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>